77 related articles for article (PubMed ID: 23108363)
1. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and activity evaluation of novel multitargeted l-tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease.
Zeng X; Cheng S; Li H; Yu H; Cui Y; Fang Y; Yang S; Feng Y
Arch Pharm (Weinheim); 2024 May; 357(5):e2300603. PubMed ID: 38290060
[TBL] [Abstract][Full Text] [Related]
5. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD
Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Human Cholinesterases and in vitro β-Amyloid Aggregation by Rationally Designed Peptides.
Sanchis I; Spinelli R; Dias J; Brazzolotto X; Rietmann Á; Aimaretti F; Siano ÁS
ChemMedChem; 2023 Jun; 18(12):e202200691. PubMed ID: 36995341
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.
Mohamed T; Zhao X; Habib LK; Yang J; Rao PP
Bioorg Med Chem; 2011 Apr; 19(7):2269-81. PubMed ID: 21429752
[TBL] [Abstract][Full Text] [Related]
8. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
[TBL] [Abstract][Full Text] [Related]
9. New 3-amino-2-thioxothiazolidin-4-one-based inhibitors of acetyl- and butyryl-cholinesterase: synthesis and activity.
Krátký M; Nováčková K; Svrčková K; Švarcová M; Štěpánková Š
Future Med Chem; 2024 Jan; 16(1):59-74. PubMed ID: 38047370
[No Abstract] [Full Text] [Related]
10. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
[TBL] [Abstract][Full Text] [Related]
11. Acetyl- and butyryl-cholinesterase inhibitory activities of the edible brown alga Eisenia bicyclis.
Choi JS; Haulader S; Karki S; Jung HJ; Kim HR; Jung HA
Arch Pharm Res; 2015 Aug; 38(8):1477-87. PubMed ID: 25370610
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of dual-target inhibitors for the treatment of Alzheimer's disease.
Zhai J; Hao C; Wang X; Cao Y; Pan Y; Zhou M; Sun J; Li C
Arch Pharm (Weinheim); 2024 May; 357(5):e2300693. PubMed ID: 38332316
[TBL] [Abstract][Full Text] [Related]
13. N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase.
Heise N; Friedrich S; Temml V; Schuster D; Siewert B; Csuk R
Eur J Med Chem; 2022 Jan; 227():113947. PubMed ID: 34731766
[TBL] [Abstract][Full Text] [Related]
14. Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly.
Thamban Chandrika N; Fosso MY; Tsodikov OV; LeVine Iii H; Garneau-Tsodikova S
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878304
[TBL] [Abstract][Full Text] [Related]
15. Structural Insights into the Marine Alkaloid Discorhabdin G as a Scaffold towards New Acetylcholinesterase Inhibitors.
Defant A; Carloni G; Innocenti N; Trobec T; Frangež R; Sepčić K; Mancini I
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667790
[TBL] [Abstract][Full Text] [Related]
16. Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?
Zueva IV; Vasilieva EA; Gaynanova GA; Moiseenko AV; Burtseva AD; Boyko KM; Zakharova LY; Petrov KA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003588
[TBL] [Abstract][Full Text] [Related]
17. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia.
Zhao FC; Wu Y; Song XJ
Med Sci Monit; 2017 Jul; 23():3311-3317. PubMed ID: 28687725
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors.
Stevens CB; Hanna JM; Lammi RK
Bioorg Med Chem Lett; 2013 Mar; 23(6):1703-6. PubMed ID: 23403086
[TBL] [Abstract][Full Text] [Related]
19. Computational selection of inhibitors of Abeta aggregation and neuronal toxicity.
Chen D; Martin ZS; Soto C; Schein CH
Bioorg Med Chem; 2009 Jul; 17(14):5189-97. PubMed ID: 19540126
[TBL] [Abstract][Full Text] [Related]
20. Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation.
Mancini RS; Wang Y; Weaver DF
Front Neurosci; 2018; 12():735. PubMed ID: 30369868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
